Novonix Ltd Adr Stock Alpha and Beta Analysis

NVX Stock  USD 1.90  0.04  2.06%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Novonix Ltd ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in Novonix over a specified time horizon. Remember, high Novonix's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Novonix's market risk premium analysis include:
Beta
3.8
Alpha
0.17
Risk
8.21
Sharpe Ratio
0.0719
Expected Return
0.59
Please note that although Novonix alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Novonix did 0.17  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Novonix Ltd ADR stock's relative risk over its benchmark. Novonix Ltd ADR has a beta of 3.80  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Novonix will likely underperform. At this time, Novonix's Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 0.36 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (5.33) in 2024.

Enterprise Value

298.78 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Novonix Backtesting, Novonix Valuation, Novonix Correlation, Novonix Hype Analysis, Novonix Volatility, Novonix History and analyze Novonix Performance.

Novonix Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Novonix market risk premium is the additional return an investor will receive from holding Novonix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Novonix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Novonix's performance over market.
α0.17   β3.80

Novonix expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Novonix's Buy-and-hold return. Our buy-and-hold chart shows how Novonix performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Novonix Market Price Analysis

Market price analysis indicators help investors to evaluate how Novonix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novonix shares will generate the highest return on investment. By understating and applying Novonix stock market price indicators, traders can identify Novonix position entry and exit signals to maximize returns.

Novonix Return and Market Media

The median price of Novonix for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 is 1.94 with a coefficient of variation of 15.91. The daily time series for the period is distributed with a sample standard deviation of 0.3, arithmetic mean of 1.89, and mean deviation of 0.24. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
We Think NOVONIX Has A Fair Chunk Of Debt
09/26/2024
2
3 ASX All Ords shares just got BIG upgrades from top brokers
11/06/2024
3
Novonix and Stellantis Sign Major Synthetic Graphite Supply Deal
11/11/2024
4
This ASX tech stock is down 93 percent from its highs. Could Trump tariffs give it a boost
11/21/2024
5
Novonix Shares Surge 11 percent After Signing Key Offtake Agreement with Volkswagens PowerCo
11/25/2024
6
Volkswagen Commits To Massive Novonix EV Component Supply Deal
11/26/2024
7
Hot Stocks on ASX Resolute Mining, AVJennings, SG Fleet, Novonix Gaining Momentum
11/29/2024

About Novonix Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Novonix or other stocks. Alpha measures the amount that position in Novonix Ltd ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield0.01880.0167
Price To Sales Ratio20.1419.13

Novonix Upcoming Company Events

As portrayed in its financial statements, the presentation of Novonix's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Novonix's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Novonix's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Novonix. Please utilize our Beneish M Score to check the likelihood of Novonix's management manipulating its earnings.
4th of October 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View
4th of October 2023
Next Fiscal Year End
View
31st of March 2023
Last Quarter Report
View
30th of June 2022
Last Financial Announcement
View

Build Portfolio with Novonix

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.